35
Participants
Start Date
May 22, 2017
Primary Completion Date
July 14, 2020
Study Completion Date
July 14, 2020
Acthar Gel
Acthar Gel 1 mL (80U) for subcutaneous injection
Placebo
Placebo for subcutaneous injection
University of Buffalo, Buffalo
Wake Forest University School of Medicine, Winston-Salem
Multiple Sclerosis Center of Atlanta, Atlanta
Meridian Clinical Research LLC, Savannah
Tallahassee Neurological Clinic, PA, Tallahassee
Neurology Associates, P. A., Maitland
University of Miami - Miller School of Medicine, Miami
University of South Florida, Bradenton
The Cleveland Clinic Foundation, Cleveland
Northern Ohio Neuroscience, LLC, Sandusky
University of Cincinnati Physicians Company, LLC, Dayton
Fort Wayne Neurological Center, Fort Wayne
Consultants in Neurology LTD, Northbrook
OSF Healthcare System Saint Francis Medical Center, Peoria
University of Kansas Medical Center Research Institute, Inc., Kansas City
Texas Neurology, PA, Dallas
Neurology Center of San Antonio, San Antonio
Advanced Neurosciences Research LLC, Fort Collins
University of New Mexico, Albuquerque
Stanford University Medical Center, Palo Alto
Wayne State University (WSU) - Multiple Sclerosis Treatment and Clinical Research Center (MS Center), Detroit
MultiCare Neuroscience Center of WA, Tacoma
Lead Sponsor
Mallinckrodt ARD LLC
INDUSTRY